Canada markets closed

Centessa Pharmaceuticals plc (260.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.50+0.05 (+0.59%)
At close: 03:29PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2020-12-31
Total Revenue
6,853
6,853
0
0
Operating Expenses
Research Development
124,405
124,405
155,083
9,301
Selling General and Administrative
53,731
53,731
55,200
1,139
Total Operating Expenses
178,136
178,136
210,283
10,440
Operating Income or Loss
-171,283
-171,283
-210,283
-10,440
Interest Expense
9,906
9,906
7,277
378
Total Other Income/Expenses Net
-5,428
-5,428
362
155
Income Before Tax
-176,141
-176,141
-216,954
-10,663
Income Tax Expense
-25,056
-25,056
-747
-
Income from Continuing Operations
-151,085
-151,085
-216,207
-10,663
Net Income
-151,085
-151,085
-216,207
-10,663
Net Income available to common shareholders
-151,085
-151,085
-216,207
-10,663
Basic EPS
-0.15
-1.57
-2.31
-0.15
Diluted EPS
-0.15
-1.57
-2.31
-0.15
Basic Average Shares
70,891
96,178
93,401
70,891
Diluted Average Shares
70,891
96,178
93,401
70,891